Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

The study identified the top 10 most important areas for future hair loss research.

Direct patients with alopecia areata to Alopecia UK, the National Alopecia Areata Foundation, and Health Talk for the best online psychological support.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

The UK Court of Appeal ruled that new dosing regimens for drugs can be patented, aligning with the European Patent Office's approach.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

People with androgenetic alopecia may have a higher genetic risk for cardiovascular diseases.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Using electronic health records can help identify drug side effects but has some limitations.

People with hair loss feel distressed and need better, trustworthy information sources.

Alopecia patients in the UK want more empathy and better care from healthcare providers, including more GP training on alopecia and improved care pathways.

Epidermolysis bullosa in UK calves is not caused by mutations in keratin genes.

Low-dose oral minoxidil is increasingly used by dermatologists in the UK and Ireland to treat various hair loss conditions.

Alopecia areata causes significant financial strain, especially for women and those with severe symptoms.

Alopecia areata impacts mental well-being more due to perceptions and stigma than disease severity.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

No significant link between male pattern baldness and COVID-19 severity was found.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

Alopecia Areata affects daily life but can lead to new activities.

Alopecia areata treatments often don't lead to lasting improvement.

A woman's rare hair loss condition improved on its own, suggesting this type might recover like common cases.

No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.

VLDL could be an early warning sign for male pattern baldness.

Six new hair loss factors in men not linked to female hair loss.

More research is needed on alopecia areata treatments and its psychological effects.